$OVTZ

2020 Q4 Form 10-K Financial Statement

#000143774921006065 Filed on March 15, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $226.8K $83.61K $37.08K
YoY Change 623.28% 93.99% -46.63%
% of Gross Profit
Research & Development $93.27K $35.33K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $350.9K $176.9K $72.42K
YoY Change 1019.01% 310.4% 4.22%
Operating Profit -$297.0K -$84.42K
YoY Change 589.06% 21.49%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income -$2.318M -$297.0K -$84.42K
YoY Change 8213.7%
Income Tax
% Of Pretax Income
Net Earnings -$2.318M -$297.0K -$84.42K
YoY Change 8212.98% 593.59% 21.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$34.63K -$3.432K -$1.174K
COMMON SHARES
Basic Shares Outstanding 86.52M 67.02M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $490.2K $695.8K $869.4K
YoY Change 28.17% 68.53% 82.8%
Cash & Equivalents $490.2K $695.8K $869.4K
Short-Term Investments
Other Short-Term Assets $6.080K $4.690K $3.070K
YoY Change 378.74% 542.47% 36.44%
Inventory
Prepaid Expenses $1.030K
Receivables
Other Receivables
Total Short-Term Assets $496.3K $700.5K $872.5K
YoY Change 29.33% 69.36% 82.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.967M $1.967M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.00 $1.967M $1.967M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $496.3K $700.5K $872.5K
Total Long-Term Assets $2.00 $1.967M $1.967M
Total Assets $496.3K $2.667M $2.839M
YoY Change 29.33% 544.9% 494.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.67K $50.61K $51.91K
YoY Change 230.23% 519.46% 17.31%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $168.1K $186.1K $181.2K
YoY Change 24.11% 35.4% 14.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $168.1K $186.1K $181.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $168.1K $186.1K $181.2K
YoY Change 24.11% 35.4% 14.04%
SHAREHOLDERS EQUITY
Retained Earnings -$44.16M -$41.84M -$41.54M
YoY Change 6.7% 1.17% 0.55%
Common Stock $43.79M $43.91M $43.79M
YoY Change 5.17% 5.46% 5.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $328.2K $2.481M $2.658M
YoY Change
Total Liabilities & Shareholders Equity $496.3K $2.667M $2.839M
YoY Change 29.33% 544.9% 494.18%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$2.318M -$297.0K -$84.42K
YoY Change 8212.98% 593.59% 21.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$205.7K -$173.6K -$344.7K
YoY Change 575.59% 176.69% -51.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $114.2K
YoY Change
Cash From Investing Activities $0.00 $0.00 $114.2K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 773.0K
YoY Change -34.3%
NET CHANGE
Cash From Operating Activities -205.7K -173.6K -344.7K
Cash From Investing Activities 0.000 0.000 114.2K
Cash From Financing Activities 0.000 0.000 773.0K
Net Change In Cash -205.7K -173.6K 542.5K
YoY Change 575.59% 176.69% 15.49%
FREE CASH FLOW
Cash From Operating Activities -$205.7K -$173.6K -$344.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001107280
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86522569
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Public Float
EntityPublicFloat
22800000
CY2020 dei Entity Registrant Name
EntityRegistrantName
OCULUS VISIONTECH INC.
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12g Title
Security12gTitle
Common Shares
CY2020 dei Trading Symbol
TradingSymbol
ovtz
CY2020Q1 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
73269
CY2020Q2 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
84417
CY2020Q3 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
296973
CY2020Q4 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
2317825
CY2020 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
2772484
CY2019Q1 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
52680
CY2019Q2 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
69486
CY2019Q3 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
42817
CY2019Q4 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
27882
CY2019 ovtz Costs And Expenses Including Other Income
CostsAndExpensesIncludingOtherIncome
192865
CY2020 ovtz Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
CY2019 ovtz Gain Loss On Settlement Of Accounts Payable
GainLossOnSettlementOfAccountsPayable
3307
CY2020Q4 ovtz Working Capital Deficit
WorkingCapitalDeficit
328205
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32329
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5431
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16670
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5048
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15659
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
383
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
284793
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
32416
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
414128
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
284793
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
CY2020Q4 us-gaap Assets
Assets
496272
CY2019Q4 us-gaap Assets
Assets
383719
CY2020 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
1380427
CY2019 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
CY2020 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
114169
CY2019 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
490190
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
382452
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
382452
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5572
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
490190
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107738
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
376880
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86522569
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67022568
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86522569
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67022568
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
44073257
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
41634999
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
2772580
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
196621
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6755000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6586000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
31116000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6755000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6586000
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
135738
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
129985
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1966939
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5052
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1267
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-259655
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51446
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5753
CY2019 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-555436
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4815
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
75
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
96
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
449
CY2020 us-gaap Interest Paid Net
InterestPaidNet
CY2019 us-gaap Interest Paid Net
InterestPaidNet
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
496272
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
383719
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
168067
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
135416
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
773038
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1176702
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
114169
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-779469
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-799822
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2772484
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-192865
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-183279
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-73269
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-84417
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-296973
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-2317825
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-52680
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-69486
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-42817
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-27882
CY2020 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1966939
CY2019 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
CY2020 us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
414128
CY2019 us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
CY2020 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
172384
CY2019 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
96
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3756
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-2772580
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-196621
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6082
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1267
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1030
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
773038
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1176702
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
254281
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44159180
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41386696
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2020Q1 us-gaap Revenues
Revenues
CY2020Q2 us-gaap Revenues
Revenues
CY2020Q3 us-gaap Revenues
Revenues
CY2020Q4 us-gaap Revenues
Revenues
CY2020 us-gaap Revenues
Revenues
CY2019Q1 us-gaap Revenues
Revenues
CY2019Q2 us-gaap Revenues
Revenues
CY2019Q3 us-gaap Revenues
Revenues
CY2019Q4 us-gaap Revenues
Revenues
CY2019 us-gaap Revenues
Revenues
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
266567
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
196621
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
284793
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
CY2020 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1380427
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1176702
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
773038
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328205
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
248303
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-735534
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div>
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
414128
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75356815
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57032157

Files In Submission

Name View Source Status
0001437749-21-006065-index-headers.html Edgar Link pending
0001437749-21-006065-index.html Edgar Link pending
0001437749-21-006065.txt Edgar Link pending
0001437749-21-006065-xbrl.zip Edgar Link pending
ex_233734.htm Edgar Link pending
ex_233735.htm Edgar Link pending
ex_233736.htm Edgar Link pending
ex_233737.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ovtz-20201231.xml Edgar Link completed
ovtz-20201231.xsd Edgar Link pending
ovtz-20201231_cal.xml Edgar Link unprocessable
ovtz-20201231_def.xml Edgar Link unprocessable
ovtz-20201231_lab.xml Edgar Link unprocessable
ovtz-20201231_pre.xml Edgar Link unprocessable
ovtz20201231_10k.htm Edgar Link pending
ovtz20201231_10kimg001.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending